We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
- Authors
Versiani, Marcio; Moreno, Ricardo; Ramakers-van Moorsel, Catharina J A; Schutte, Albert J; Comparative Efficacy Antidepressants Study Group
- Abstract
Depression is a major global problem associated with large medical, sociological and economic burdens. Mirtazapine (Remeron, Organon NV, The Netherlands) is an antidepressant with a unique mechanism of action that has similar or superior efficacy to TCAs and SSRIs in moderate-to-severe depression. However, this agent has not yet been tested in patients with severe depression alone.
- Publication
CNS drugs, 2005, Vol 19, Issue 2, p137
- ISSN
1172-7047
- Publication type
Journal Article
- DOI
10.2165/00023210-200519020-00004